Surface Oncology, Inc.·4

Feb 5, 4:10 PM ET

Nogelo Liisa I 4

4 · Surface Oncology, Inc. · Filed Feb 5, 2020

Insider Transaction Report

Form 4
Period: 2020-02-03
Nogelo Liisa I
General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-02-03+90,00090,000 total
    Exercise: $3.18Exp: 2030-02-03Common Stock (90,000 underlying)
  • Award

    Common Stock

    2020-02-03+80,00080,000 total
Footnotes (2)
  • [F1]The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in full on the date 18 months after January 21, 2020, so long as the reporting person remains an employee or other service provider of the Company on such date.
  • [F2]This option shall become exercisable in equal monthly installments over four years following January 21, 2020, so long as the reporting person remains an employee or other service provider of the Company on such dates.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION